Ligand Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.About LGND
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.
CEOTodd Christopher Davis
CEOTodd Christopher Davis
Employees68
Employees68
HeadquartersJupiter, Florida
HeadquartersJupiter, Florida
Founded1987
Founded1987
Employees68
Employees68
LGND Key Statistics
Market cap3.72B
Market cap3.72B
Price-Earnings ratio91.00
Price-Earnings ratio91.00
Dividend yield—
Dividend yield—
Average volume176.53K
Average volume176.53K
High today$193.54
High today$193.54
Low today$188.25
Low today$188.25
Open price$189.91
Open price$189.91
Volume81.29K
Volume81.29K
52 Week high$212.49
52 Week high$212.49
52 Week low$93.58
52 Week low$93.58
Stock Snapshot
Ligand Pharmaceuticals(LGND) stock is priced at $189.07, giving the company a market capitalization of 3.72B. It carries a P/E multiple of 91.00.
As of 2026-01-01, Ligand Pharmaceuticals(LGND) stock has fluctuated between $188.25 and $193.54. The current price stands at $189.07, placing the stock +0.4% above today's low and -2.3% off the high.
The Ligand Pharmaceuticals(LGND)'s current trading volume is 81.29K, compared to an average daily volume of 176.53K.
During the past year, Ligand Pharmaceuticals(LGND) stock moved between $93.58 at its lowest and $212.49 at its peak.
During the past year, Ligand Pharmaceuticals(LGND) stock moved between $93.58 at its lowest and $212.49 at its peak.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.